Adial Pharmaceuticals ADIL Q4 2025 Annual earnings
Reported March 10, 2026 · Before market open
EPS-$1.81Beat by $0.29
EPS estimate-$2.10
Next report
Aug 12, 2026 (In 1 week)EPS estimate-$1.02
Versus estimates
Diluted EPS
Ask the moment Adial Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Adial Pharmaceuticals report Q4 2025 earnings?
- Adial Pharmaceuticals (ADIL) reported Q4 2025 earnings on March 10, 2026 before market open.
- What were Adial Pharmaceuticals's Q4 2025 revenue and EPS?
- Adial Pharmaceuticals reported eps of $-1.81 for Q4 2025.
- Did Adial Pharmaceuticals beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-2.10 by $0.29.
- How did Adial Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 1106.7% from $-0.15.
- Where can I find Adial Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001213900-26-024175) directly on SEC EDGAR. The filing index links above go to sec.gov.